Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S.

Tumori
Maria Di BartolomeoFilippo Pietrantonio

Abstract

No predictive markers for chemotherapy activity have been validated in gastric cancer (GC). The potential value of class III β-tubulin (TUBB3) as biomarker for prognosis and resistance to taxane-based therapy was reported. We analyzed GC samples of patients enrolled in the Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S), a randomized adjuvant study comparing 5-fluorouracil/leucovorin (5-FU/LV) and docetaxel-based sequential chemotherapy. TUBB3 was quantitated by selected reaction monitoring mass spectrometry and patients were stratified using a threshold of 750 attomoles per microgram (amol/µg). Cox proportional modeling and Kaplan-Meier survival analysis were used to assess the impact of TUBB3 expression on overall survival (OS) and disease-free survival. Patients with TUBB3 protein levels >750 and <750 amol/µg were 21.9% and 78.1%, respectively, and were well-balanced between treatment arms. TUBB3 protein levels were not prognostic. Whereas no survival differences according to the 2 arms were observed in the subgroup with low TUBB3 expression (5-year OS 47% vs 40%; p = 0.44), patients with high TUBB3 had a clinically meaningful poorer OS when receiving docetaxel-based versus 5-FU/LV chemot...Continue Reading

References

Jun 11, 1999·British Journal of Cancer·M KavallarisS B Horwitz
Dec 5, 1958·Annals of the New York Academy of Sciences·R L NOBLEJ H CUTTS
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pascal SèveTony Reiman
Feb 2, 2008·The Lancet Oncology·Pascal Sève, Charles Dumontet
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vyomesh PatelJ Silvio Gutkind
Apr 30, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Antonis M PolitisConstantin R Soldatos
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlos M GalmariniCharles Dumontet
May 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y KohD S Heo
Oct 10, 2009·Journal of the National Cancer Institute·Richard M SimonDaniel F Hayes
Jan 16, 2010·Journal of the National Cancer Institute·Boris FreidlinEdward L Korn
Mar 8, 2011·Medicinal Research Reviews·Richard A StantonRitu Aneja
Oct 18, 2011·Current Molecular Medicine·M MarianiC Ferlini
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M McShane, Daniel F Hayes
Mar 28, 2013·Medical Oncology·Vladimir M MoiseyenkoEvgeny N Imyanitov
Apr 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaUNKNOWN ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group
May 2, 2014·World Journal of Gastroenterology : WJG·Rosalba MiceliFilippo Pietrantonio
Jul 9, 2014·The Pharmacogenomics Journal·E CaiolaM Marabese
Jul 16, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jingwei YuLin Shen
Apr 12, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Maria Di BartolomeoRosalba Miceli
Oct 1, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E AnY-J Bang
Jul 26, 2018·Pharmacogenomics·Alessandra RaimondiFilippo Pietrantonio
Jan 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E AnY-J Bang
Jul 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaUNKNOWN ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group
Oct 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Salah-Eddin Al-Batran

❮ Previous
Next ❯

Software Mentioned

[UNK]

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.